oxybutynin chloride 5 mg/1 TABLET, EXTENDED RELEASE
Accord Healthcare, Inc.
FDA Drug Information
Indications & Usage
1 INDICATIONS AND USAGE Oxybutynin chloride extended-release tablets are a muscarinic antagonist indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency, and frequency. Oxybutynin chloride extended-release tablets are also indicated for the treatment of pediatric patients aged 6 years and older with symptoms of detrusor overactivity associated with a neurological condition (e.g., spina bifida). Oxybutynin chloride extended-release tablets are a musca…
Source: FDA. For professional use only. Not a substitute for prescribing information.
Other oxybutynin chloride NDC Codes
Wholesale and compliance resources
Order NDC 16729-0317-01 at Wholesale
Create a free Premier Pharma account to unlock live wholesale pricing and place orders with same-day fulfillment and full DSCSA T2 documentation (TI + TS).